[Federal Register Volume 89, Number 135 (Monday, July 15, 2024)]
[Notices]
[Page 57419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15391]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Council on Blood Stem Cell 
Transplantation (ACBSCT or Advisory Council) has scheduled public 
meetings. Information about the Advisory Council and the agenda for 
these meetings can be found on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

DATES: Thursday, August 22, 2024, 2:00 p.m.-6:00 p.m. Eastern Standard 
Time; and Thursday, October 24, 2024, 2:00 p.m.-6:00 p.m. Eastern 
Standard Time.

ADDRESSES: Both meetings will be held virtually by webinar. A link to 
register and join each meeting will be posted at least 10 days prior to 
the meeting date at: https://bloodstemcell.hrsa.gov/about/advisory-council.

FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal 
Official, HRSA Health Systems Bureau, Division of Transplantation, 5600 
Fishers Lane, 8W-67, Rockville, Maryland 20857; 301-443-8036; or 
[email protected].

SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations 
to the Secretary of Health and Human Services on policy, program 
development, and other matters of significance concerning the 
activities under the authority of 42 U.S.C. 274k (Section 379 of the 
Public Health Service Act), as amended, and Public Law 109-129, as 
amended. The Advisory Council may transmit its recommendations through 
the HRSA Administrator on matters related to the activities of the C.W. 
Bill Young Cell Transplantation Program and National Cord Blood 
Inventory.
    The agenda for the August 22, 2024, meeting is being finalized and 
may include the following topics: criteria for defining a high-quality 
cord blood unit for banking specifications; the unmet needs in blood 
stem cell transplantation and cellular therapy; updates on transplant 
outcomes by different donor sources; strategies to improve rates of 
donation for adult blood stem cell donors; and other areas to increase 
blood stem cell donation and transplantation. The agenda for the 
October 24, 2024, meeting will be determined based on discussion, 
priorities, and/or action items from the August 22, 2024, meeting. All 
agenda items will be posted on the Advisory Council's website no later 
than 10 days prior to the respective meeting dates. Agenda items are 
subject to change as priorities dictate. Interested individuals are 
encouraged to monitor the Advisory Council's website for any updated 
information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meetings; oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACBSCT should be 
sent to Shelley Tims Grant, using the contact information above, at 
least 3 business days prior to the meeting.
    Individuals who plan to attend and need special assistance or other 
reasonable accommodations should notify Advisory Council at the address 
and phone number listed above at least 10 business days prior to the 
meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-15391 Filed 7-12-24; 8:45 am]
BILLING CODE 4165-15-P